~nytimes-most-popular | Bookmarks (1)

clear filters

drugs (pharmaceuticals) × eli lilly and company ×

F.D.A. Delays Action on Closely Watched Alzheimer’s Drug

nytimes.com

Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to...
Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.

alzheimer's alzheimer's disease donanemab drugs (pharmaceuticals)eli lilly
1